[1] Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis[J]. Curr Treat Options Oncol, 2008, 9(23): 147157.
[2] Chen LY, Huang LX, Wang J, et al. Malignant peritoneal mesothelioma presenting with persistent high fever[J]. J Zhejiang Univ Sci B, 2011, 12(5): 381384.
[3] 白植军, 陈道达. 女性弥漫性恶性腹膜间皮瘤的诊断与治疗[J]. 中国实用外科杂志, 2003, 23(6): 358359.
[4] 李智宇, 崔修铮, 邵永孚, 等. 恶性腹膜间皮瘤的诊治体会[J]. 中国肿瘤临床, 2008, 34(23): 13651367.
[5] 徐梅梅, 郑岳. 腹腔镜在恶性腹膜间皮瘤诊断中的应用 50 例分析[J]. 中国误诊学杂志, 2008 (1): 186187.
[6] Ordóez NG. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study[J]. Mod Pathol, 2006, 19(1): 3448.
[7] Taylor P, Castagneto B, Dark G, et al. Singleagent pemetrexed for chemonave and pretreated patients with malignant pleural mesothelioma: results of an International Expanded Access Program[J]. J Thorac Oncol, 2008, 3(7): 764771.
[8] 丁为庆, 陶相光, 师恩义. TIL 细胞腹腔内输注治愈腹膜间皮瘤恶性腹水 1 例[J]. 中国肿瘤临床, 2003, 30(1): 1313. |